Playing at the edges, navigating sexual boundaries, and narrating sexual distress; Practices and perspectives of sexuality and gender diverse people who use GHB.

Int J Drug Policy

National Centre for Clinical Research on Emerging Drugs, c/o the University of New South Wales, Sydney 2052, Australia; The National Drug and Alcohol Research Centre (NDARC), the University of New South Wales, Sydney 2052, Australia; Alcohol and Drug Service, St Vincent's Hospital Sydney, Darlinghurst 2010, Australia.

Published: October 2022

Background: Research addressing sexualised use of GHB to date has largely focussed on gay and bisexual men's GHB use in the context of chemsex, this research has highlighted risks and experiences associated with sexual violence. No studies have included people of diverse sexualities and genders and documented reported practices to ensure mutually gratifying and consensual sex in the context of sexualised drug use (SDU).

Methods: Semi-structured interviews were conducted with 31 people from sexuality and gender diverse communities living in Australia who reported three or more occasions of GHB use in the previous 12 months. Participants were asked about their use of GHB for sex, their experiences of GHB sex and their approaches to negotiating sexual boundaries. Data were analysed thematically.

Results: Most participants valued the sexual possibilities enabled by disinhibitory components of GHB and were cognisant of respecting other's sexual boundaries in the context of GHB sex. Participants reported strategies to ensure communication prior to and throughout GHB sex. However, several participants narrated experiences of GHB sex that they felt were distressing and, in some circumstances, sexually violent. In most instances participant's resisted terminology of sexual violence or non-consent as descriptors of their experience and none reported accessing sexual violence services.

Conclusion: Positive strategies to facilitate sexual communication prior to and throughout GHB sex should be reflected in health promotion and service level responses to promote affirmative and continuous consent among people who use GHB for sex. Education initiatives to help people engaged in SDU to recognise and respond to sexual violence if it occurs ought to be prioritised.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drugpo.2022.103811DOI Listing

Publication Analysis

Top Keywords

ghb sex
28
sexual violence
16
sexual boundaries
12
ghb
12
sexual
10
sexuality gender
8
gender diverse
8
people ghb
8
sex
8
experiences ghb
8

Similar Publications

Article Synopsis
  • The study aimed to identify factors associated with false positives in cardiopulmonary exercise tests (CPET) for diagnosing coronary heart disease (CHD), focusing on blood glucose and lipid levels.
  • A comparison was made between 103 subjects with false positive results and 65 with true positive results, noting that males, smokers, and diabetes patients were less likely to be in the false positive group, which also had higher HDL and lower blood glucose levels.
  • The findings suggest that fasting blood glucose (FBG) and glycosylated hemoglobin (GHb) might help differentiate between true and false positives, especially in females, making FBG a useful predictor of false positives in suspected CHD cases.
View Article and Find Full Text PDF

Literature is sparse regarding men's attitudes towards male sexual assault and the role that the sexuality of those involved may have. Despite the high prevalence of chemsex and GHB (gamma-hydroxybutyrate) participation among men who have sex with men, no study has yet investigated attitudes towards such. Utilising a community sample of 141 UK men, participants were randomly assigned into one of six conditions based on victim sexuality (heterosexual or homosexual) and the drug used present during the sexual assault (chemsex, chemical submission, or no drugs).

View Article and Find Full Text PDF
Article Synopsis
  • This study explored the experiences of harm and mental health issues among gay, bisexual, and other men who have sex with men (GBMSM) involved in chemsex, specifically looking at the use of methamphetamine and GHB/GBL.
  • A survey was conducted with 510 participants in Taiwan, revealing different levels of harm based on drug combinations used during chemsex sessions.
  • Results indicated that those using both methamphetamine and GHB/GBL faced significantly higher rates of social, physical, and psychological harm compared to those who used only one or none of the drugs.
View Article and Find Full Text PDF

Objectives: The study aimed to estimate the prevalence of sexualized drug use, or chemsex, in a wide group of gay, bisexual and other men who have sex with men (gbMSM) in Belgium. It examined which drugs gbMSM used before and during sex, the frequency with which they used it, whether they experienced non-consensual sex, and evaluated the impact of chemsex on the health and professional and social lives of respondents.

Methods: We conducted an online survey among Belgian gbMSM.

View Article and Find Full Text PDF

Chemsex describes the use of specific substances (methamphetamine, GHB/GBL, mephedrone, ketamine) which initiate or enhance sexual experiences and is mainly prevalent among men who have sex with men. Many Chemsex users experience somatic complications (for example sexually transmitted diseases) and sometimes adverse sociological, psychological, and neurological symptoms, such as depression, impulse control disorders or hypersexuality. Changes in impulsivity and deficits in executive functions have demonstrated to be associated with addiction and impulse control disorders as well as frontal brain dysfunction and behavioral control deficits.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!